Iruma-gun

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Childhood cancers1 trial
• Chronic myeloid leukaemia1 trial
• Diabetic eye disease1 trial
• Familial hypercholesterolaemia1 trial
• Immune thrombocytopenia (ITP)1 trial
• Systemic sclerosis (scleroderma)1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Active, not recruiting3 trials
• Completed3 trials

Lead sponsor

• Novartis Pharmaceuticals6 trials

Running trials

• Active, not recruiting

  A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis

  NCT06470048· Phase 2· Novartis Pharmaceuticals· Source

• Active, not recruiting

  Specified Drug-use Survey of Leqvio for s.c. Injection.

  NCT06275724· Novartis Pharmaceuticals· Source

• Active, not recruiting

  Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP)

  NCT05653349· Phase 3· Novartis Pharmaceuticals· Source

Closed trials

• Completed

  Special Drug Use Observational Study With Beovu Kit for Intravitreal Injection

  NCT05526729· Novartis Pharmaceuticals· Source

• Completed

  Special Drug Use-results Surveillance of Scemblix Tablets

  NCT05421091· Novartis Pharmaceuticals· Source

• Completed

  Study of Efficacy and Safety of Canakinumab in Japanese Patients With AOSD

  NCT04717635· Phase 3· Novartis Pharmaceuticals· Source